XXXIXth conference on hyperlipoproteinemias – Šobraʼs Day 2025
Authors:
Kristýna Čillíková; Karolína Vašků
Authors‘ workplace:
Česká společnost pro aterosklerózu
Published in:
AtheroRev 2025; 10(2): 139-141
Category:
Annoucements
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2025 Issue 2
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Memantine Eases Daily Life for Patients and Caregivers
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
-
All articles in this issue
- Editorial
- Bempedoic acid – an efficient and safe lipid-lowering treatment in the light of the latest findings
- Factors influencing hypolipidemic treatment of patients after acute coronary syndrome, ischemic stroke, and transient ischemic attack in cardiological and neurological outpatient care in Slovakia
- Fats and oils from the perspective of scientific studies, the media and the internet
- Evinacumab in the treatment of homozygous familial hypercholesterolemia: data from real-world clinical practice and case report
- Effect of once-weekly semaglutide on functional capacity in patients with peripheral arterial disease and type 2 diabetes: results from the STRIDE study
- Coronary events are preventable – so don't miss this opportunity: case report
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – the current challenges for its management
- Where does the Czech Republic have a head start, and where does it need to catch up? International Summit on Lipoprotein(a) – Brussels, March 2025
- Research on remarkable articles from international literature
- XXXIXth conference on hyperlipoproteinemias – Šobraʼs Day 2025
- Athero Review
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Bempedoic acid – an efficient and safe lipid-lowering treatment in the light of the latest findings
- Factors influencing hypolipidemic treatment of patients after acute coronary syndrome, ischemic stroke, and transient ischemic attack in cardiological and neurological outpatient care in Slovakia
- Fats and oils from the perspective of scientific studies, the media and the internet
- Where does the Czech Republic have a head start, and where does it need to catch up? International Summit on Lipoprotein(a) – Brussels, March 2025